CPT1A and pulmonary arterial hypertension: Finally, therapeutic upregulation of Cpt1a using pharmacological treatments and nanoparticle‐mediated endothelial gene delivery as well as blockage of EndoMT were employed to determine their effects on neonatal hyperoxia‐induced pulmonary vascular remodeling and pulmonary hypertension.